Executive compensation plays a critical role in preparing for a successful IPO. In the fifth episode of BioDech, a global life sciences broadcast series, Kevin Kay, partner in Dechert's Employee Benefits and Executive Compensation practice, is joined by guest speakers John Schultz, Managing Director and co-head of the Compensation and Benefits practice at Alvarez & Marsal, and Brennan Rittenhouse, Managing Director at Alvarez & Marsal, to discuss understanding the market, identifying your organization’s peer groups, designing competitive compensation components, and other regulatory and disclosure requirements.